Provided By GlobeNewswire
Last update: Nov 3, 2025
Highly experienced biopharma financial officer joins leadership team
CFO hire bolsters Kalaris’ leadership team and supports continued growth of the company as it enrolls its Phase 1b/2 study in treatment naïve nAMD patients
Read more at globenewswire.com9.13
-1.29 (-12.38%)
Find more stocks in the Stock Screener


